Recombinant adenoviral vectors can induce expression of p73 via the E4-orf6/7 protein

被引:7
|
作者
Shapiro, Gary S.
Van Peursem, Crystal
Ornelles, David A.
Schaack, Jerome
DeGregori, James
机构
[1] Univ Colorado, Dept Biochem & Mol Genet, Dept Pediat, Integrated Dept Immunol,Program Mol Biol, Aurora, CO 80045 USA
[2] Ctr Hlth Sci, Aurora, CO 80045 USA
[3] Wake Forest Univ, Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27157 USA
[4] Univ Colorado, Dept Microbiol, Program Mol Biol, Aurora, CO 80045 USA
关键词
D O I
10.1128/JVI.02016-05
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Despite the utility of recombinant adenoviral vectors in basic research, their therapeutic promise remains unfulfilled. Most engineered adenoviral vectors use a heterologous promoter to transcribe a foreign gene. We show that adenoviruses containing the cytomegalovirus immediate-early promoter induce the expression of the proapoptotic cellular protein TAp73 via the cyclin-dependent kinase-retinoblastoma protein-E2F pathway in murine embryonic fibroblasts. Cells transduced with these vectors also expressed high levels of the adenoviral E4-orf6/7 and E2A proteins. By contrast, adenoviruses containing the ubiquitin C promoter failed to elicit these effects. E4-orf6/7 is necessary and sufficient for increased TAp73 expression, as shown by using retrovirus-mediated E4-orf6/7 expression and adenovirus with the E4-orf6/7 gene deleted. Activation of TAp73 likely occurs via E4-orf6/7-induced dimerization of E2F and subsequent binding to the inverted E2F-responsive elements within the TAp73 promoter. In addition, adenoviral vectors containing the cytomegalovirus immediate-early promoter, but not the ubiquitin C promoter, cooperated with chemotherapeutic agents to decrease cellularity in vitro. In contrast to murine embryonic fibroblasts, adenoviruses containing the ubiquitin C promoter, but not the cytomegalovirus immediate-early promoter, induced both E4-orf6/7 and TAp73 in human foreskin fibroblasts, emphasizing the importance of cellular context for promoter-dependent effects. Because TAp73 is important for the efficacy of chemotherapy, adenoviruses that increase TAp73 expression may enhance cancer therapies by promoting apoptosis. However, such adenoviruses may impair the long-term survival of transduced cells during gene replacement therapies. Our findings reveal previously unknown effects of foreign promoters in recombinant adenoviral vectors and suggest means to improve the utility of engineered adenoviruses by better controlling their impact on viral and cellular gene expression.
引用
收藏
页码:5349 / 5360
页数:12
相关论文
共 50 条
  • [21] Identification of three functions of the adenovirus E4orf6 protein that mediate p53 degradation by the E4orf6-E1B55K complex (vol 75, pg 699, 2001)
    Querido, E
    Morrison, MR
    Chu-Pham-Dang, H
    Thirlwell, SWL
    Boivin, D
    Branton, PE
    JOURNAL OF VIROLOGY, 2001, 75 (05) : 2508 - 2508
  • [22] The adenovirus E4orf6 protein can promote E1A/E1B-induced focus formation by interfering with p53 tumor suppressor function
    Nevels, M
    Rubenwolf, S
    Spruss, T
    Wolf, H
    Dobner, T
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (04) : 1206 - 1211
  • [23] Induction of transformation and p53-dependent apoptosis by adenovirus type 5 E4orf6/7 cDNA
    Yamano, S
    Tokino, T
    Yasuda, M
    Kaneuchi, M
    Takahashi, M
    Niitsu, Y
    Fujinaga, K
    Yamashita, T
    JOURNAL OF VIROLOGY, 1999, 73 (12) : 10095 - 10103
  • [24] Role of viral oncoproteins E6 and E7 in p16INK4a expression
    SI-Mohammed, Ali
    ANNALES DE PATHOLOGIE, 2010, 30 : S103 - S104
  • [25] The E4-6/7 protein functionally compensates for the loss of E1A expression in adenovirus infection
    O'Connor, RJ
    Hearing, P
    JOURNAL OF VIROLOGY, 2000, 74 (13) : 5819 - 5824
  • [26] A conserved region of unknown function participates in the recognition of E2F family members by the adenovirus E4 ORF 6/7 protein
    Jost, CA
    Ginsberg, D
    Kaelin, WG
    VIROLOGY, 1996, 220 (01) : 78 - 90
  • [27] The adenovirus E4orf6 protein contributes to malignant transformation by antagonizing E1A-induced accumulation of the tumor suppressor protein p53
    Michael Nevels
    Thilo Spruss
    Hans Wolf
    Thomas Dobner
    Oncogene, 1999, 18 : 9 - 17
  • [28] The large E1B protein together with the E4orf6 protein target p53 for active degradation in adenovirus infected cells
    Wilma T Steegenga
    Nicole Riteco
    A G Jochemsen
    Frits J Fallaux
    Johannes L Bos
    Oncogene, 1998, 16 : 349 - 357
  • [29] The adenovirus E4orf6 protein contributes to malignant transformation by antagonizing E1A-induced accumulation of the tumor suppressor protein p53
    Nevels, M
    Spruss, T
    Wolf, H
    Dobner, T
    ONCOGENE, 1999, 18 (01) : 9 - 17
  • [30] The large E1B protein together with the E4orf6 protein target p53 for active degradation in adenovirus infected cells
    Steegenga, WT
    Riteco, N
    Jochemsen, AG
    Fallaux, FJ
    Bos, JL
    ONCOGENE, 1998, 16 (03) : 349 - 357